DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity

Yao Li(Guangzhou Institutes of Biomedicine and Health), Peng Li(Chinese Academy of Sciences), Pentao Liu(Hong Kong Science and Technology Parks Corporation), Xiaofei Zhang(Guangzhou Institutes of Biomedicine and Health), Youguo Long(Chinese Academy of Sciences), Wenbin Gu(Guangzhou Institutes of Biomedicine and Health), Mingwei Sun(Guangzhou Institutes of Biomedicine and Health), Qiting Wu(Chinese Academy of Sciences), Diwei Zheng(Wuhan University), Xiangqian Kong(University of Science and Technology of China), Yao Yao(Dalian Medical University), Jie Wang(Shanghai University of Traditional Chinese Medicine), Le Qin(Shanghai Jiao Tong University), Shanglin Li(Tsinghua University), Linfu Zhou(Nanjing Medical University), Shouheng Lin(Chinese Academy of Sciences), Dongdong Peng(Guangzhou Institutes of Biomedicine and Health), Jiongliang Wang(Chinese Academy of Sciences)
Science Immunology
March 21, 2025
Cited by 23


Related Papers